Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Second Quarter, 1997 - Quarterly Biosafety Listings - Office of Laboratory Security

Quarterly Biosafety Listings


Second Quarter, 1997


Corry JE, et al. Salmonella, Campylobacter and Escherichia coli 0157:H7 decontamination techniques for the future. Int J Food Microbiol. 1995;28(2):187-196.

Fink TM Rodents, human remains, and North American hantaviruses: risk effects and prevention measures for forensic science personnel - a review. J Forensic Sci. 1996;41(6):1052-1056.

Friel JK, et al. Laboratory gloves as a source of trace element contamination. Biol Trace Elem Res. 1996;54(2):135-142.

Gandsman EJ, et al. Sabia virus incident at Yale University. Am Indust Hyg Assoc J. 1997;58(1):51-53.

Grammont-Cupillard M, et al. Brucellosis from sniffing bacteriological cultures. (letter) Lancet. 1996;348(9043):1733-1734.

Gutierrez CB, et al. Efficacy of a variety of disinfectants against Actinobacillus pleuropneumoniae serotype 1. Am J Vet Res. 1995;56(8):1025-1029.

Hackstadt T Biosafety concerns and Coxiella burnettii. (letter) Trends Microbiol.1996;4(9):341-342.

Jernigan DB, et al. Outbreak of Legionnaire's disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet. 1996;347(9000):494-499.

Kappel TJ, et al. The viability of Mycobacterium tuberculosis in formalin-fixed pulmonary autopsy tissue: a review of the literature and brief report. Hum Pathol. 1996;27(12):1361-1364.

Kaul R, et al. Investigation of a multiyear critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality. J Infect Dis. 1996;1974(6):1279-1287.

McCoy CB, et al. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp. 1995;43(1):1-9.

Mellstrom GA, et al. The value and limitations of protective gloves in medical health service; Part II. Dermatol Nurs. 1996;8(4):287-285.

Nolte KB, et al. Hantaviral biosafety issues in the autopsy room and laboratory: concerns and recommendations. Hum Pathol. 1996;27(12):1253-1254.

Oie S, et al. Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios. 1996;85(345):223-230.

Ojeh CK, et al. Evaluation of the effects of disinfectants on rotavirus RNA and infectivity by the polymerase chain reaction and cell-culture methods. Mol Cell Probes. 1995;9(5):341-346.

Phillips G, et al. Laboratory-acquired VTEC Infection. J Hosp Infect. 1997;35(1):72.

Ridley RM, et al. Oral transmission of BSE to primates. (letter) Lancet. 1996;348(9035):1174.

Taylor DM, et al. The response of the 22A strain of scrapie agent to microwave irradiation compared with boiling. Neuropathol Appl Neurobiol. 1996;22(3): 256-258.

Taylor D Inactivation of the causal agents of Creutzfeldt-Jakob disease and other human prion diseases. (letter) Brain Pathol. 1996;6(2):197-198.

Taylor DM, et al. Inactivation of the bovine spongiform encephalophathy agent by rendering procedures. Vet Rec. 1995;137(24):605-610.

Van Bueren J, et al. Inactivation of HIV-I by chemical disinfectants: sodium hypochlorite. Epidemiol Infect. 1995;115(3):567-579.

Whitbourne J, et al. Sterilization of reusable medical devices: evaluation of a liquid chemical sterilization process using peracetic acid. Minim Invasiv Surg Nurs. 1995;9(3):111-117.

Yamanaka A, et al. Disinfectant effects of "Taisalite" and "Taifresh Ace" containing Irgasan DP300 against MRSA and HIV. Bull Tokyo Dent Coll. 1993;34(4):167-171

© 1998 Health Canada

[Office of Laboratory Security] [Quarterly Biosafety Listings]